Prescriber Acceptability of a Direct-to-Patient Intervention for Benzodiazepine Receptor Agonist Deprescribing and Behavioural Management of Insomnia in Older Adults
Behavioural treatments are recommended first-line for insomnia, but long-term benzodiazepine receptor agonist (BZRA) use remains common and engaging patients in a deprescribing consultation is challenging. Few deprescribing interventions directly target patients. Prescribers' support of patient-targeted interventions may facilitate their uptake. Recently assessed in the Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study, Sleepwell (mysleepwell.ca) was developed as a direct-to-patient behaviour change intervention promoting BZRA deprescribing and non-pharmacological insomnia management. BZRA prescribers of YAWNS NB participants were invited to complete an online survey assessing the acceptability of Sleepwell as a direct-to-patient intervention. The survey was developed using the seven construct components of the theoretical framework of acceptability (TFA) framework. Respondents (40/250, 17.2%) indicated high acceptability, with positive responses per TFA construct averaging 32.3/40 (80.7%). Perceived as an ethical, credible, and useful tool, Sleepwell also promoted prescriber-patient BZRA deprescribing engagements (11/19, 58%). Prescribers were accepting of Sleepwell and supported its application as a direct-to-patient intervention.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Canadian journal on aging = La revue canadienne du vieillissement - (2024) vom: 08. März, Seite 1-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Murphy, Andrea L [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 08.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1017/S0714980824000114 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36945989X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36945989X | ||
| 003 | DE-627 | ||
| 005 | 20240308233452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240308s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0714980824000114 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1320.xml |
| 035 | |a (DE-627)NLM36945989X | ||
| 035 | |a (NLM)38456246 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Murphy, Andrea L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prescriber Acceptability of a Direct-to-Patient Intervention for Benzodiazepine Receptor Agonist Deprescribing and Behavioural Management of Insomnia in Older Adults |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Behavioural treatments are recommended first-line for insomnia, but long-term benzodiazepine receptor agonist (BZRA) use remains common and engaging patients in a deprescribing consultation is challenging. Few deprescribing interventions directly target patients. Prescribers' support of patient-targeted interventions may facilitate their uptake. Recently assessed in the Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study, Sleepwell (mysleepwell.ca) was developed as a direct-to-patient behaviour change intervention promoting BZRA deprescribing and non-pharmacological insomnia management. BZRA prescribers of YAWNS NB participants were invited to complete an online survey assessing the acceptability of Sleepwell as a direct-to-patient intervention. The survey was developed using the seven construct components of the theoretical framework of acceptability (TFA) framework. Respondents (40/250, 17.2%) indicated high acceptability, with positive responses per TFA construct averaging 32.3/40 (80.7%). Perceived as an ethical, credible, and useful tool, Sleepwell also promoted prescriber-patient BZRA deprescribing engagements (11/19, 58%). Prescribers were accepting of Sleepwell and supported its application as a direct-to-patient intervention | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a acceptability | |
| 650 | 4 | |a acceptabilité | |
| 650 | 4 | |a benzodiazepines | |
| 650 | 4 | |a benzodiazépines | |
| 650 | 4 | |a comportements en matière de santé | |
| 650 | 4 | |a deprescribing | |
| 650 | 4 | |a déprescription | |
| 650 | 4 | |a health behaviour | |
| 650 | 4 | |a participation des patients | |
| 650 | 4 | |a patient participation | |
| 650 | 4 | |a primary health care | |
| 650 | 4 | |a soins de santé primaires | |
| 700 | 1 | |a Turner, Justin P |e verfasserin |4 aut | |
| 700 | 1 | |a Rajda, Malgorzata |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Kathleen G |e verfasserin |4 aut | |
| 700 | 1 | |a Gardner, David M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Canadian journal on aging = La revue canadienne du vieillissement |d 1993 |g (2024) vom: 08. März, Seite 1-9 |w (DE-627)NLM08680734X |x 1710-1107 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:08 |g month:03 |g pages:1-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S0714980824000114 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 08 |c 03 |h 1-9 | ||